FDA Inspection 1281036 — Intas Pharmaceuticals Ltd.
The FDA completed an inspection of Intas Pharmaceuticals Ltd. on Sep 16, 2025 in Selaqui. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI)
- End Date
- Sep 16, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Selaqui (India)